Stocksigma LogoStocksigma Logo

Arvaya Healthcare Reports Robust Q2 FY27 Performance with Aggressive HMO Expansion Strategy

Arvaya Healthcare reported Q2 FY27 revenue from operations of ₹40.28 Cr, up 35% QoQ, with EBITDA rising 32% QoQ to ₹5.24 Cr (13.0% margin) and PAT surging

Arvaya Healthcare Reports Robust Q2 FY27 Performance with Aggressive HMO Expansion Strategy

Bijoy Hans Ltd · Investor Presentation · 16 Nov 2026, 9:04 pm

Arvaya Healthcare Reports Robust Q2 FY27 Performance with Aggressive HMO Expansion Strategy Arvaya Healthcare reported Q2 FY27 revenue from operations of ₹40.28 Cr, up 35% QoQ, with EBITDA rising 32% QoQ to ₹5.24 Cr (13.0% margin) and PAT surging 157% QoQ to ₹1.37 Cr. H1 FY27 revenue reached ₹70.19 Cr with PAT of ₹1.90 Cr. Operational beds expanded to 517 across 9 hospitals, driving ARPOB up 17% YoY to ₹23,651 and inpatient discharges up 38% YoY to 5,526. The company targets ~2,400 beds and a ₹600 Cr revenue trajectory by FY30 via an asset-light HMO model.

Original exchange filing (PDF)

More announcements from Bijoy Hans Ltd

All Bijoy Hans Ltd announcements